Organon & Co. Statistics

Total Valuation

Organon & Co. has a market cap or net worth of GBP 3.32 billion. The enterprise value is 9.80 billion.

Market Cap	3.32B
Enterprise Value	9.80B

Important Dates

The next estimated earnings date is Friday, February 14, 2025.

Earnings Date	Feb 14, 2025
Ex-Dividend Date	Nov 12, 2024

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+0.92%
Shares Change (QoQ)	+0.45%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	256.70M

Valuation Ratios

The trailing PE ratio is 3.42.

PE Ratio	3.42
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 6.59, with an EV/FCF ratio of 17.59.

EV / Earnings	10.10
EV / Sales	1.88
EV / EBITDA	6.59
EV / EBIT	8.03
EV / FCF	17.59

Financial Position

The company has a current ratio of 1.70, with a Debt / Equity ratio of 17.75.

Current Ratio	1.70
Quick Ratio	0.89
Debt / Equity	17.75
Debt / EBITDA	4.78
Debt / FCF	11.71
Interest Coverage	2.91

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	7.91%
Return on Capital (ROIC)	10.86%
Revenue Per Employee	478,175
Profits Per Employee	97,068
Employee Count	10,000
Asset Turnover	0.54
Inventory Turnover	2.08

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +2.22% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+2.22%
50-Day Moving Average	15.38
200-Day Moving Average	18.77
Relative Strength Index (RSI)	55.77
Average Volume (20 Days)	2,019

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	5.31

Income Statement

In the last 12 months, Organon & Co. had revenue of GBP 4.78 billion and earned 970.68 million in profits. Earnings per share was 3.76.

Revenue	4.78B
Gross Profit	2.79B
Operating Income	1.12B
Pretax Income	583.45M
Net Income	970.68M
EBITDA	1.32B
EBIT	1.12B
Earnings Per Share (EPS)	3.76

Full Income Statement

Balance Sheet

The company has 569.27 million in cash and 6.53 billion in debt, giving a net cash position of -5.96 billion.

Cash & Cash Equivalents	569.27M
Total Debt	6.53B
Net Cash	-5.96B
Net Cash Per Share	n/a
Equity (Book Value)	367.83M
Book Value Per Share	1.43
Working Capital	1.47B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 705.81 million and capital expenditures -148.47 million, giving a free cash flow of 557.34 million.

Operating Cash Flow	705.81M
Capital Expenditures	-148.47M
Free Cash Flow	557.34M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 58.26%, with operating and profit margins of 23.47% and 20.30%.

Gross Margin	58.26%
Operating Margin	23.47%
Pretax Margin	12.20%
Profit Margin	20.30%
EBITDA Margin	27.52%
EBIT Margin	23.47%
FCF Margin	11.66%

Dividends & Yields

This stock pays an annual dividend of 0.88, which amounts to a dividend yield of 5.56%.

Dividend Per Share	0.88
Dividend Yield	5.56%
Dividend Growth (YoY)	-2.93%
Years of Dividend Growth	n/a
Payout Ratio	22.75%
Buyback Yield	-0.92%
Shareholder Yield	4.64%
Earnings Yield	29.25%
FCF Yield	16.79%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Organon & Co. has an Altman Z-Score of 1.41. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.41
Piotroski F-Score	n/a